Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT

Journal of Virological Methods

Volumn 67, Issue 2, 1997, Pages 199-207

  Bruisten, S M ^a   Oudshoorn, P ^b   Van Swieten, P ^a   Boeser Nunnink, B ^a   Van Aarle, P ^b   Tondreau, S P ^c   Cuypers, H T M ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b Organon Teknika   (Netherlands)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

Author keywords

HIV 1 RNA; NASBA QT; Stability; Storage conditions

Indexed keywords

EDETIC ACID; HEPARIN; VIRUS RNA;

ARTICLE; BLOOD; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STORAGE; VIRUS DIAGNOSIS;

BLOOD PRESERVATION; BUFFERS; EDETIC ACID; GENE AMPLIFICATION; HEPARIN; HIV INFECTIONS; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RIBONUCLEASES; RNA, VIRAL; SPECIMEN HANDLING; TEMPERATURE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030771867     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00097-9     Document Type: Article

References (25)

1. Beutler, E., Gelbart, T., Kuhl, W., 1990. Interference of heparin with polymerase chain reaction. BioTechniques 90, 166-167.
2. Boom, R., Sol, C.J.A., Salimans, M.M.M., Jansen, C.L., Wertheim-van Dillen, P.M.E., Van der Noordaa, J., 1990. A rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28, 495-503.
3. Bruisten, S.M., Frissen, P.H.J., van Swieten, P., Harrigan, P.R., Kinghorn, I., Larder, B., Weigel, H.M., De Vries, E., Regez, R.M., Henrichs, J.H., Koot, M., Huisman, J.G., 1997. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV-1 infected persons. AIDS Res Hum Retroviruses 13, 327-335.
4. Busch, M.P., Wilber, J.C., Johnson, P., Tobler, L., Evans, C.S., 1992. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 32, 420-425.
5. Cuypers, H.T.M., Bresters, D., Winkel, I.N., Reesink, H.W., Weiner, A.J., Houghton, M., Van der Poel, C.L., Lelie, P.N., 1992. Storage conditions of blood samples and primer selection affect the yield of cDNA-polymerase chain reaction products of hepatitis C virus. J. Clin. Microbiol. 30, 3220-3224.
6. Holodniy, M., Katzenstein, D.A., Sengupta, S., Wang, A.M., Casipit, C., Schwartz, D.H., Konrad, M., Groves, E., Merigan, T.C., 1991a. Detection and quantitation of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J. Infect. Dis. 163, 862-866.
7. Holodniy, M., Kim, S., Katzenstein, D., Konrad, M., Groves, E., Merigan, T.C., 1991b. Inhibition of human immunodeficiency virus gene amplification by heparin. J. Clin. Microbiol. 29, 676-679.
8. Holodniy, M., Mole, L., Yen-Lieberman, B., Margolis, D., Starkey, C., Carroll, R., Spahlinger, T., Todd, J., Jackson, J.B., 1995. Comparative stabilities of human immunodeficiency virus RNA in plasma from samples collected in Vacutainer CPT, Vacutainer PPT, and standard Vacutainer tubes. J. Clin. Microbiol. 33, 1562-1566.
9. Jurriaans, S., van Gemen, B., Weverling, G.J., Van Strijp, D., Nara, P., Coutinho, R.A., Koot, M., Schuitemaker, H., Goudsmit, J., 1994. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?. Virology 204, 223-233.
10. The ACTG 175 Virology Study Team, Katzenstein, D.A., Hammer, S.M., Hughes, M.D., Gundacker, H., Jackson, J.B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., Merigan, T.C., Hirsch, M.S., 1996. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200-500 CD4 cells per cubic millimeter. N. Engl. J. Med. 335, 1091-1098.
11. Mellors, J.W., Rinaldo, C., Gupta, P., White, R.M., Todd, J.A., Kingsley, L.A., 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170.
12. Moudgil, T., Daar, E.S., 1993. Infectious decay of human immunodeficiency virus type 1 in plasma. J. Infect. Dis. 167, 210-212.
13. Mulder, J., McKinney, N., Christopherson, C., Sninsky, J., Greenfield, L., Kwok, S., 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32, 292-300.
14. Revets, H., Marissens, D., de Wit, S., Lacor, P., Clumeck, N., Lauwers, S., Zissis, G., 1996. Comparative evaluation of NASBA HIV-1 RNA QT, Amplicor-HIV monitor, and Quantiplex HIV RNA assay, three methods for quantification of HIV-1 RNA in plasma. J. Clin. Microbiol. 34, 1058-1064.
15. Saag, M.S., Holodniy, M., Kuritzkes, D.R., O'Brien, W.A., Coombs, R., Poscher, M.E., Jacobsen, D.M., Shaw, G.M., Richman, D.D., Volberding, P.A., 1996. HIV viral load markers in clinical practice. Nat. Med. 2, 625-629.
16. Schuurman, R., Descamps, D., Weverling, G.J., Kaye, S., Tijnagel, J., Williams, I., Van Leeuwen, R., Tedder, R., Boucher, C.A.B., Brun-Vezinet, F., Loveday, C., 1996. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34, 3016-3022.
17. Tersmette, M., De Goede, R.E.Y., Al, B.J.M., Winkel, I.N., Gruters, R.A., Cuypers, H.T.M., Huisman, H.G., Miedema, F., 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62, 2026-2032.
18. Todd, J., Pachl, C., White, R., Yeghiazarian, T., Johnson, P., Taylor, B., Holodniy, M., Kern, D., Hamren, S., Chernoff, D., Urdea, M., 1995. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J. Acquir. Immune Defic. Syndr. 10 (2), S35-S44.
19. van Gemen, B., Kievits, T., Schukkink, R., Van Strijp, D., Malek, L.T., Sooknanan, R., Huisman, H.G., Lens, P., 1993. Quantitation of HIV-1 RNA in plasma using NASBA™ during HIV-1 primary infection. J. Virol. Methods 43, 177-188.
20. The Belgian AIDS Reference Laboratories, Vandamme, A.-M., Fransen, K., Debaisieux, L., Marissens, D., Sprecher, S., Vaira, D., Vandenbroucke, A.T., Verhofstede, C., 1995. Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. J. Virol. Methods 51, 305-316.
21. Vandamme, A.-M., Schmit, J.-C., van Dooren, S., van Laethem, K., Gobbers, E., Kok, W., Goubau, P., Witvrouw, M., Peetermans, W., De Clerq, E., Desmyter, J., 1996. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the Amplicor HIV monitor test. J. Acquir. Immune Defic. Syndr. 13, 127-139.
22. Verhofstede, C., Fransen, K., Marissens, D., Verhelst, R., Groen van der, G., Lauwers, S., Zissis, G., Plum, J., 1996. Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods. J. Virol. Methods 60, 155-159.
23. Vernazza, P.L., Eron, J.J., Fiscus, S.A., 1993. Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count. J. Infect. Dis. 168, 1269-1272.
24. Wang, J.T., Wang, T.-H., Sheu, J.-C., Lin, S.-M., Lin, J.-T., Chen, D.-S., 1992. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J. Clin. Microbiol. 30, 750-753.
25. Winters, M.A., Tan, L.B., Katzenstein, D.A., Merigan, T.C., 1993. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J. Clin. Microbiol. 31, 2960-2966.